Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,022 | -15,424 | -14,323 | -7,711 | -3,584 |
| Depreciation Amortization | 1 | 1 | 2 | 1 | 1 |
| Other Working Capital | 392 | -518 | -1,580 | -5,091 | 119 |
| Other Operating Activity | 2,306 | 2,535 | 2,823 | 1,510 | 140 |
| Operating Cash Flow | $-12,323 | $-13,405 | $-13,078 | $-11,291 | $-3,325 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 17,141 | -16,600 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | -4 | N/A |
| Other Investing Activity | 0 | 0 | 173 | 452 | 0 |
| Investing Cash Flow | $N/A | $17,141 | $-16,427 | $448 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,511 | N/A | N/A | 390 | N/A |
| Other Financing Activity | -763 | 0 | 0 | 47,947 | 1,163 |
| Financing Cash Flow | $4,748 | $N/A | $N/A | $48,338 | $1,163 |
| Beginning Cash Position | 13,362 | 9,627 | 39,132 | 1,638 | 3,799 |
| End Cash Position | 5,787 | 13,362 | 9,627 | 39,132 | 1,638 |
| Net Cash Flow | $-7,575 | $3,735 | $-29,505 | $37,495 | $-2,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,323 | -13,405 | -13,078 | -11,291 | -3,325 |
| Capital Expenditure | N/A | N/A | N/A | -4 | N/A |
| Free Cash Flow | -12,323 | -13,405 | -13,078 | -11,294 | -3,325 |